Pathologic gene network rewiring implicates PPP1R3A as a central regulator in pressure overload heart failure.
Pablo CorderoVictoria N ParikhElizabeth T ChinAyca ErbilginMichael J GloudemansChing ShangYong HuangAlex Chia Yu ChangKevin S SmithFrederick DeweyKathia ZaletaMichael MorleyJeff BrandimartoNicole GlazerDaryl WaggottAleksandra PavlovicMingming ZhaoChristine S MoravecW H Wilson TangJamie SkreenChristine MalloySridhar HannenhalliHongzhe LiScott RitterMingyao LiDaniel BernsteinAndrew ConnollyHakon HakonarsonAldons J LusisKenneth B MarguliesAnna A Depaoli-RoachStephen B MontgomeryMatthew T WheelerThomas CappolaEuan A AshleyPublished in: Nature communications (2019)
Heart failure is a leading cause of mortality, yet our understanding of the genetic interactions underlying this disease remains incomplete. Here, we harvest 1352 healthy and failing human hearts directly from transplant center operating rooms, and obtain genome-wide genotyping and gene expression measurements for a subset of 313. We build failing and non-failing cardiac regulatory gene networks, revealing important regulators and cardiac expression quantitative trait loci (eQTLs). PPP1R3A emerges as a regulator whose network connectivity changes significantly between health and disease. RNA sequencing after PPP1R3A knockdown validates network-based predictions, and highlights metabolic pathway regulation associated with increased cardiomyocyte size and perturbed respiratory metabolism. Mice lacking PPP1R3A are protected against pressure-overload heart failure. We present a global gene interaction map of the human heart failure transition, identify previously unreported cardiac eQTLs, and demonstrate the discovery potential of disease-specific networks through the description of PPP1R3A as a central regulator in heart failure.
Keyphrases
- genome wide
- heart failure
- left ventricular
- dna methylation
- gene expression
- copy number
- transcription factor
- endothelial cells
- cardiac resynchronization therapy
- acute heart failure
- healthcare
- poor prognosis
- atrial fibrillation
- high throughput
- small molecule
- induced pluripotent stem cells
- cardiovascular disease
- single cell
- white matter
- cardiovascular events
- skeletal muscle
- long non coding rna
- angiotensin ii
- neoadjuvant chemotherapy
- human health
- binding protein
- locally advanced
- climate change
- network analysis
- health information